Virpax Pharmaceuticals downgraded to Hold at Maxim on capital constraints
PremiumThe FlyVirpax Pharmaceuticals downgraded to Hold at Maxim on capital constraints
2M ago
Virpax Pharmaceuticals downgraded to Hold from Buy at Maxim
PremiumThe Fly
Virpax Pharmaceuticals downgraded to Hold from Buy at Maxim
2M ago
Virpax Pharmaceuticals prices $2.25M public offering at $1.35 per share
PremiumThe Fly
Virpax Pharmaceuticals prices $2.25M public offering at $1.35 per share
2M ago
Virpax Pharmaceuticals’ Settlement Strain: Risk of Stalled Development and Hindered Growth
PremiumCompany AnnouncementsVirpax Pharmaceuticals’ Settlement Strain: Risk of Stalled Development and Hindered Growth
4M ago
Scilex enters release, settlement agreement with Virpax Pharmaceuticals
PremiumThe Fly
Scilex enters release, settlement agreement with Virpax Pharmaceuticals
4M ago
Virpax Pharmaceuticals Inc trading halted, news pending
PremiumThe Fly
Virpax Pharmaceuticals Inc trading halted, news pending
5M ago
Virpax Pharmaceuticals CEO Anthony Mack resigns
PremiumThe FlyVirpax Pharmaceuticals CEO Anthony Mack resigns
8M ago
Virpax says CRADA with USAISR to evaluate Probudur extended to September 2024
PremiumThe Fly
Virpax says CRADA with USAISR to evaluate Probudur extended to September 2024
10M ago
Virpax Pharmaceuticals announces results of Probudur dose escalation studies
PremiumThe Fly
Virpax Pharmaceuticals announces results of Probudur dose escalation studies
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100